The Gould Syndrome Clinic at University of California, San Francisco, founded in spring 2024, demonstrates a multidisciplinary model for patient-centered care focused on individuals with COL4A1 and COL4A2 variants. The clinic offers in-person and telehealth visits, emphasizes collaboration with local providers including neurosurgeons and ophthalmologists, and allows for patient contributions to research. In the year since the clinic’s inception, 20 patients from 18 families (ages 11 months to 25 years) were seen, with a range of neurological complications including stroke (60%), cerebral palsy (75%), epilepsy (55%), and developmental differences (100%).
Non-neurologic issues were also common, notably ophthalmologic abnormalities (70%), gastrointestinal dysmotility (60%), and obstructive sleep apnea (40%). Common themes included diagnostic delays, care complexity, and hope for increased provider awareness. Challenges included geographic dispersion, insurance barriers, and integration into existing clinical workflows. Moving forward, the clinic aims to expand its natural history registry (which has currently enrolled over 50 participants), collect biospecimens research including clinical trial development, and deepen understanding of underexplored systemic complications. Collaboration with other institutions and broader provider education remain priorities.
Patient voices emphasize the need for informed care, preventive strategies, and continued research into disease-modifying therapies. The initiative highlights the importance of comprehensive, specialized care for this rare and complex condition with clinical implications across the lifespan.
Funding
This research received no external funding.
Institutional Review Board Statement
Not applicable as the data represented in this abstract was not part of a research study.
Informed Consent Statement
Not applicable as the data represented in this abstract was not part of a research study.
Data Availability Statement
Additional data about the individuals seen in the clinic is unavailable due to privacy restrictions on protected health information. Access to de-identified data is available upon reasonable request.
Acknowledgments
During the preparation of this abstract the author used ChatGPT 4.0 for the purposes of summarizing the data. The author has reviewed and edited the output and takes full responsibility for the content of this publication.
Conflicts of Interest
The author declares no conflict of interest.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).